Version 1
: Received: 17 December 2023 / Approved: 18 December 2023 / Online: 18 December 2023 (10:34:03 CET)
How to cite:
Mbiya, B.M.; Mbuyi, D.K.; Kasongo, S.T.; Daubie, V. Managing of Acute Pediatric Cough in Africa: prescription of Cough Suppressants and Associated Complications. Preprints2023, 2023121235. https://doi.org/10.20944/preprints202312.1235.v1
Mbiya, B.M.; Mbuyi, D.K.; Kasongo, S.T.; Daubie, V. Managing of Acute Pediatric Cough in Africa: prescription of Cough Suppressants and Associated Complications. Preprints 2023, 2023121235. https://doi.org/10.20944/preprints202312.1235.v1
Mbiya, B.M.; Mbuyi, D.K.; Kasongo, S.T.; Daubie, V. Managing of Acute Pediatric Cough in Africa: prescription of Cough Suppressants and Associated Complications. Preprints2023, 2023121235. https://doi.org/10.20944/preprints202312.1235.v1
APA Style
Mbiya, B.M., Mbuyi, D.K., Kasongo, S.T., & Daubie, V. (2023). Managing of Acute Pediatric Cough in Africa: prescription of Cough Suppressants and Associated Complications. Preprints. https://doi.org/10.20944/preprints202312.1235.v1
Chicago/Turabian Style
Mbiya, B.M., Steve Tshiala Kasongo and Valery Daubie. 2023 "Managing of Acute Pediatric Cough in Africa: prescription of Cough Suppressants and Associated Complications" Preprints. https://doi.org/10.20944/preprints202312.1235.v1
Abstract
Background: The use of antitussives is a crucial issue in pediatrics and can lead to respiratory complications that can affect the prognosis.
Objectives: to determine the frequency of respiratory complications associated with the use of an-titussives in pediatrics in a remote city in the Democratic Republic of Congo.
Method: This is a cross-sectional retrospective study conducted between January 1, 2017 and De-cember 2022. Patients under 12 years of age with an acute cough were eligible. The parameters studied were treatment with cough suppressants and associated respiratory complications.
Results: A total of 218 children suffered from an acute cough. The average age was 11 months 10, the sex ratio (H/F) was 126/92. In 30% of cases, children were treated with cough suppressants for an average of 7 days prior to admission. Respiratory complications were observed in 11% (23/218) of cases. The majority of these complications, 61% (14 of 23), had received antitussive treatment prior to hospitalization. Respiratory complications were associated with cough medications (p-value = 0.0012, relative risk (RR) = 3.66, IC90 [1.696; 7,873]). Acute respiratory distress was reported in 87% (20/23) of cases and was associated with the use of cough suppressants (p-value = 0.0065, RR: 3.060, IC90: [1.433; 6,485]).
Conclusion: The use of antitussives in pediatrics poses a risk of acute respiratory distress in a remote city that does not have sufficient human and material resources for management.
Keywords: cough, cough suppressants, pediatrics, complications, Mbujimayi, Democratic Republic of Congo.
Keywords
cough; cough suppressants; pediatrics; complications; Mbujimayi; Democratic Republic of Congo
Subject
Medicine and Pharmacology, Pediatrics, Perinatology and Child Health
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
